Aratana Therapeutics To Announce Third Quarter 2018 Financial Results

Arantana Therapeutics will host a live conference call on Friday, November 2, 2018 at 8:30 a.m.

Therapeutics is a pet company concerned with licensing, development and commercialization of innovative therapeutics for dogs and cats, will host a live conference call on Friday, November 2, 2018 at 8:30 a.m. Highlight of this program will include detailed discussion of the financial results from the third quarter ended September 30, 2018.

For Interested participants and investors who wish to access the audio webcast or call, you could use the conference call dial-in:

A review of the third quarter 2018 results teleconference will be available the same day of the event by approximately 11 a.m. ET and an audio webcast will be accessible for 90 days in the Aratana Investor Room. For a replay of the call, use the below dial-in and conference ID 10125816:

1 (877) 344-7529 (U.S.) 1 (855) 669-9658 (Canada) 1 (412) 317-0088 (International)About Aratana Therapeutics Aratana Therapeutics is a pet therapeutics company that is concerned with licensing, developing and commercializing innovative therapeutics for dogs and cats. As a pioneer in pet therapeutics, Aratana's mission is to deliver safe and effective therapeutics that elevate the standard of care in veterinary medicine. We work with companion animal veterinarians to bring new therapeutics to market that support the needs of pets and their owners.